This conference explored how technology and innovation have transformed the way consumers pay for purchases. It also looked at which reforms to current legislative and regulatory structures may be necessary to support continued payment innovation.

Biopharma – especially big pharma – gets all sorts of grief for being large, stodgy, and unable to innovate (or evolve); this Corey Goodman interview represents the perspective well.

Before writing off these companies entirely, however (an ignorant reaction in any case),...

Many of the critics of the Stop Online Piracy Act (SOPA), and other legislation seeking to combat intellectual property violations on the Internet, say they are fighting efforts to “censor” the web. SOPA is many things, but if words still have meaning it cannot be fruitfully described as censorship.

Mark Zuckerberg probably never dreamed when he invented Facebook to connect college students that it would someday save a life.

All too often, industry seems to be viewed as the villain, yet industry is ultimately responsible for bringing to the market almost all new medical solutions.

A poignant story in Thursday’s Boston Globe describes how the O’Donnell family of Boston channeled their love of a son, Joey, who died tragically at the age of 12 from cystic fibrosis, into a successful mission to develop impactful new treatments for this terrible affliction.

A way to expedite digital television, expand needed wireless services, serve the public interest, and get a real return to the public for the use of its airwaves is in sight.